Mirae Asset Global ETFs Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74.7M	Sell	150,692 -21,233	-12%	-$9.41M	0.09%	215
2026 Q1	$76.6M	Buy	171,925 +1,150	+0.7%	+$536K	0.1%	190
2025 Q4	$77.2M	Buy	170,775 +4,830	+3%	+$2.08M	0.12%	180
2025 Q3	$65M	Sell	165,945 -53,488	-24%	-$22.4M	0.1%	201
2025 Q2	$97.7M	Sell	219,433 -17,792	-8%	-$8.2M	0.19%	119
2025 Q1	$115M	Buy	237,225 +47,965	+25%	+$22.4M	0.25%	87
2024 Q4	$76.2M	Buy	189,260 +567	+0.3%	+$263K	0.16%	123
2024 Q3	$87.8M	Sell	188,693 -6,162	-3%	-$2.96M	0.2%	108
2024 Q2	$91.3M	Buy	+194,855	New	+$84.6M	0.22%	104

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's VRTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, selling an estimated $9.41M and leaving 150,692 shares worth $74.7M. The position accounts for 0.09% of the portfolio, ranked #215.

Mirae Asset Global ETFs Holdings first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $115M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 150,692 shares of Vertex Pharmaceuticals worth $74.7M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 21,233 Vertex Pharmaceuticals shares in Q2 2026, an estimated $9.41M.
Vertex Pharmaceuticals made up 0.09% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #215 holding.
Mirae Asset Global ETFs Holdings first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Vertex Pharmaceuticals position peaked at $115M in Q1 2025.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.